Predictive Oncology Inc. (POAI)
POAI moved a median of -0.77% 30 minutes after news, and -1.22% by the close. How POAI actually reacts to news — the realized, point-in-time move the market made, measured across 171 labeled events over the last three years with zero look-ahead.
POAI’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 39% | 158 |
| 30-min | -0.77% | 33% | 162 |
| 60-min | -1.53% | 30% | 169 |
| to close | -1.22% | 30% | 167 |
| Middle 50% of POAI reactions | -2.78% to +1.02% |
|---|---|
| Median reaction (30-min) | -0.77% |
| Measured reactions | 171 |
Half of all Predictive Oncology Inc. news events land between -2.78% and +1.02% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when POAI moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to POAI's baseline. Nothing else.
Recent POAI events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K Axe Compute Inc. For: Dec 10 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form S-8 Axe Compute Inc. | SEC filing · Form S-8 | SEC EDGAR | — | — | |
| Form 8-K Predictive Oncology Inc. For: Dec 09 | SEC filing · Form 8-K | SEC EDGAR | -2.84% | +0.00% | |
| Form 8-K Predictive Oncology Inc. For: Dec 01 | SEC filing · Form 8-K | SEC EDGAR | +7.72% | +3.77% | |
| Predictive Oncology Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement | Press release | GlobeNewswire | +0.00% | -0.72% | |
| Form EFFECT Predictive Oncology Inc. | SEC filing · Form EFFECT | SEC EDGAR | +0.00% | +0.68% | |
| Form 8-K Predictive Oncology Inc. For: Nov 25 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.68% | |
| Form EFFECT Predictive Oncology Inc. | SEC filing · Form EFFECT | SEC EDGAR | — | -2.27% | |
| Form 8-K Predictive Oncology Inc. For: Nov 20 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +11.15% | |
| Form S-3/A Predictive Oncology Inc. | SEC filing · Form S-3 | SEC EDGAR | +0.00% | +11.15% | |
| Form 8-K Predictive Oncology Inc. For: Nov 17 | SEC filing · Form 8-K | SEC EDGAR | +0.30% | -8.43% | |
| Form 10-Q Predictive Oncology Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.30% | -8.43% | |
| Form 8-K Predictive Oncology Inc. For: Nov 14 | SEC filing · Form 8-K | SEC EDGAR | +0.30% | -8.43% | |
| Predictive Oncology Reports Third Quarter 2025 Financial Results and Provides Update on Digital Asset Strategy | Press release | GlobeNewswire | +0.30% | -8.43% | |
| Form 8-K Predictive Oncology Inc. For: Oct 29 | SEC filing · Form 8-K | SEC EDGAR | +2.20% | -2.20% | |
| Form ARS Predictive Oncology Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +0.10% | +2.00% | |
| Form DEF 14A Predictive Oncology Inc. For: Nov 25 | SEC filing · Form DEF | SEC EDGAR | +1.23% | +3.25% | |
| Form D Predictive Oncology Inc. | SEC filing · Form D | SEC EDGAR | -3.12% | -5.67% | |
| Form S-3 Predictive Oncology Inc. | SEC filing · Form S-3 | SEC EDGAR | -3.12% | -5.67% | |
| Form 8-K Predictive Oncology Inc. For: Oct 16 | SEC filing · Form 8-K | SEC EDGAR | +0.46% | -13.24% | |
| Form PRE 14A Predictive Oncology Inc. For: Nov 25 | SEC filing · Form PRE | SEC EDGAR | -2.36% | -7.17% | |
| Predictive Oncology Announces Additions to Board and Leadership Team to Support Digital Asset Treasury Strategy | Press release | GlobeNewswire | +2.12% | +2.72% | |
| Form 8-K Predictive Oncology Inc. For: Oct 07 | SEC filing · Form 8-K | SEC EDGAR | +0.19% | -1.80% | |
| Predictive Oncology Inc. Announces Closing of $343.5 Million in Private Placements to Initiate Digital Asset Treasury Strategy | Press release | GlobeNewswire | +5.50% | +2.19% | |
| Form 8-K Predictive Oncology Inc. For: Sep 25 | SEC filing · Form 8-K | SEC EDGAR | +2.83% | -7.96% | |
| Form 8-K Predictive Oncology Inc. For: Sep 29 | SEC filing · Form 8-K | SEC EDGAR | -18.72% | -35.83% | |
| Predictive Oncology Inc. Announces Private Placements of $344 Million to Initiate a Digital Asset Treasury Strategy Focused on Aethir (ATH) Tokens | Press release | GlobeNewswire | -24.41% | -43.66% | |
| Form 8-K Predictive Oncology Inc. For: Sep 19 | SEC filing · Form 8-K | SEC EDGAR | -3.45% | -18.08% | |
| Predictive Oncology Announces 1-for-15 Reverse Stock Split | Press release | GlobeNewswire | -3.45% | -18.08% | |
| Form 8-K Predictive Oncology Inc. For: Sep 09 | SEC filing · Form 8-K | SEC EDGAR | -5.18% | -2.81% | |
| Form D Predictive Oncology Inc. | SEC filing · Form D | SEC EDGAR | -4.64% | +0.83% | |
| Predictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients | Press release | GlobeNewswire | -0.56% | +1.62% | |
| Form 8-K Predictive Oncology Inc. For: Aug 26 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Form DEF 14A Predictive Oncology Inc. For: Sep 19 | SEC filing · Form DEF | SEC EDGAR | -0.11% | — | |
| Form 8-K Predictive Oncology Inc. For: Aug 14 | SEC filing · Form 8-K | SEC EDGAR | -5.94% | -4.40% | |
| Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update | Press release | GlobeNewswire | -5.94% | -4.40% | |
| Form 10-Q Predictive Oncology Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -5.94% | -4.40% | |
| Form PRE 14A Predictive Oncology Inc. For: Aug 06 | SEC filing · Form PRE | SEC EDGAR | -0.67% | -3.93% | |
| Form EFFECT Predictive Oncology Inc. | SEC filing · Form EFFECT | SEC EDGAR | +0.00% | — | |
| Form 8-K Predictive Oncology Inc. For: Jul 23 | SEC filing · Form 8-K | SEC EDGAR | -0.36% | -0.45% | |
| Form 8-K Predictive Oncology Inc. For: Dec 31 | SEC filing · Form 8-K | SEC EDGAR | -0.42% | -2.10% | |
| Form S-1 Predictive Oncology Inc. | SEC filing · Form S-1 | SEC EDGAR | -0.42% | -2.10% | |
| Predictive Oncology Issues Shareholder Letter: Well Financed to Support Expanded U.S. Availability and E.U. Launch of ChemoFx® and Pursuit of Other High-Value AI-Driven Drug Discovery and Development Opportunities | Press release | GlobeNewswire | -2.50% | -1.19% | |
| Form 8-K Predictive Oncology Inc. For: Jul 08 | SEC filing · Form 8-K | SEC EDGAR | +6.25% | +0.00% | |
| Form 8-K Predictive Oncology Inc. For: Jul 01 | SEC filing · Form 8-K | SEC EDGAR | -0.01% | +0.00% | |
| Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing | Press release | GlobeNewswire | -5.81% | -6.98% | |
| Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp | Press release | GlobeNewswire | -4.06% | +0.06% | |
| Form 8-K Predictive Oncology Inc. For: Jun 09 | SEC filing · Form 8-K | SEC EDGAR | -4.06% | +0.06% | |
| Form 8-K Predictive Oncology Inc. For: Jun 02 | SEC filing · Form 8-K | SEC EDGAR | +1.02% | +0.12% | |
| Court Denies Renovaro Motion for an Expedited Trial in July | Press release | GlobeNewswire | +0.22% | -3.51% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the POAI section they belong to.
Where else POAI is measured.
POAI earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Predictive Oncology Inc.'s median reaction calculated?
Every labeled POAI news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 171 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 33% of POAI's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does POAI's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.